Castleman disease is a lymphoproliferative disorder with a nondefinite etiology and can be classified into subtypes based on clinical and histological manifestations. Therefore, this condition's high morbidity and complications can be avoided with early diagnosis and prompt treatment. This activity explains the evaluation and treatment of Castleman disease and highlights the role of the interprofessional team in evaluating and treating patients with this condition.

**Objectives:**
- Describe the pathophysiology of Castleman disease.
- Outline the clinical signs and symptoms, common physical and laboratory findings in Castleman disease.
- Review the epidemiology and commonly associated diseases with Castleman disease.
- Summarize the management and treatment options available for Castleman disease.